---
schema_version: "secwatch.filing_event.v1"
accession: "0001021771-23-000037"
form_type: "8-K"
ticker: "BRTX"
cik: "0001505497"
company_name: "BioRestorative Therapies, Inc."
filed_at: "2023-04-06T23:59:59+00:00"
generated_at: "2026-06-17T05:06:27.081577+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.0
calibrated_materiality_score: 0.0
confidence: "high"
source: SEC EDGAR
---

# BioRestorative Therapies files accounting firm consents for S-3 registration statement

## Summary
- Filed consents of Friedman LLP and Marcum LLP to incorporate audit reports into Form S-3.
- Consents relate to reports dated March 30, 2022 and March 24, 2023 for 2022 Form 10-K.
- Purely administrative filing; no change in financial statements or business operations.
- No new financial results, guidance, or events disclosed.

## SEC filing metadata
- accession: 0001021771-23-000037
- form_type: 8-K
- ticker: BRTX
- cik: 0001505497
- company_name: BioRestorative Therapies, Inc.
- filed_at: 2023-04-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.0
- calibrated_materiality_score: 0.0
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1505497/000102177123000037/0001021771-23-000037-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1505497/000102177123000037/form8kdtd040623.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001021771-23-000037
- JSON: https://secwatch.observer/filing/0001021771-23-000037.json
- Plain text: https://secwatch.observer/filing/0001021771-23-000037.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.